ES405663A1 - Procedimiento para la obtencion de compuestos inhibidores de oxidasa de xantina. - Google Patents

Procedimiento para la obtencion de compuestos inhibidores de oxidasa de xantina.

Info

Publication number
ES405663A1
ES405663A1 ES405663A ES405663A ES405663A1 ES 405663 A1 ES405663 A1 ES 405663A1 ES 405663 A ES405663 A ES 405663A ES 405663 A ES405663 A ES 405663A ES 405663 A1 ES405663 A1 ES 405663A1
Authority
ES
Spain
Prior art keywords
pyrazola
xanthine oxidase
compounds useful
oxidase inhibitors
pyrimidine compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES405663A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch Health Americas Inc
Original Assignee
International Chemical and Nuclear Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Chemical and Nuclear Corp filed Critical International Chemical and Nuclear Corp
Publication of ES405663A1 publication Critical patent/ES405663A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES405663A 1971-08-16 1972-08-08 Procedimiento para la obtencion de compuestos inhibidores de oxidasa de xantina. Expired ES405663A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17219571A 1971-08-16 1971-08-16
US261103A US3920652A (en) 1971-08-16 1972-06-08 Aromatic substituted pyrazola {8 1,5a{9 {0 pyrimidine compounds useful as xanthine oxidase inhibitors

Publications (1)

Publication Number Publication Date
ES405663A1 true ES405663A1 (es) 1976-01-16

Family

ID=26867834

Family Applications (1)

Application Number Title Priority Date Filing Date
ES405663A Expired ES405663A1 (es) 1971-08-16 1972-08-08 Procedimiento para la obtencion de compuestos inhibidores de oxidasa de xantina.

Country Status (19)

Country Link
US (1) US3920652A (en:Method)
JP (1) JPS4834899A (en:Method)
AR (1) AR193536A1 (en:Method)
AT (1) AT330780B (en:Method)
BE (1) BE786611A (en:Method)
BG (1) BG19806A3 (en:Method)
DD (1) DD99581A5 (en:Method)
DE (1) DE2236987A1 (en:Method)
ES (1) ES405663A1 (en:Method)
FR (1) FR2150771B1 (en:Method)
GB (1) GB1359563A (en:Method)
HU (1) HU167466B (en:Method)
IE (1) IE36629B1 (en:Method)
IL (1) IL39988A0 (en:Method)
LU (1) LU65892A1 (en:Method)
MC (1) MC937A1 (en:Method)
NL (1) NL7211011A (en:Method)
RO (1) RO63871A (en:Method)
SU (1) SU522800A3 (en:Method)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093617A (en) * 1974-11-12 1978-06-06 Icn Pharmaceuticals, Inc. 3,5,7-Trisubstituted pyrazolo[1,5-a]pyrimidines
US4048184A (en) * 1976-11-15 1977-09-13 E. R. Squibb & Sons, Inc. 6-Phenyl-2H-pyrazolo[3,4-b]pyridines
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
AU557300B2 (en) * 1982-03-16 1986-12-18 Farmitalia Carlo Erba S.P.A. Substituted 1h-pyrazolo(1,5-alpha)pyrimidines and processes for their preparation
ZA831407B (en) * 1982-03-25 1983-11-30 Erba Farmitalia Substituted ethenyl derivatives of 1h-pyrazolo(1,5-a)pyrimidine and process for their preparation
WO1992006096A1 (fr) * 1990-10-09 1992-04-16 Otsuka Pharmaceutical Co., Ltd. Derive de pyrimidine, production de ce derive et inhibiteur d'androgenes
AU667575B2 (en) * 1992-10-20 1996-03-28 Otsuka Pharmaceutical Co., Ltd. Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor
KR100260292B1 (ko) * 1995-09-28 2000-07-01 오쓰카 요시미쓰 진통제
US6664261B2 (en) 1996-02-07 2003-12-16 Neurocrine Biosciences, Inc. Pyrazolopyrimidines as CRF receptor antagonists
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
ES2294800T3 (es) * 1996-07-24 2008-04-01 Bristol-Myers Squibb Pharma Company Azolo triazinas y pirimidinas.
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6235741B1 (en) * 1997-05-30 2001-05-22 Merck & Co., Inc. Angiogenesis inhibitors
WO1999024038A1 (en) * 1997-11-07 1999-05-20 Johns Hopkins University Methods for treatment of disorders of cardiac contractility
US6380203B1 (en) * 1998-01-14 2002-04-30 Merck & Co., Inc. Angiogenesis inhibitors
AU4331500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
WO2000059908A2 (en) 1999-04-06 2000-10-12 Du Pont Pharmaceuticals Company Pyrazolopyrimidines as crf antagonists
US6630476B2 (en) 2000-07-07 2003-10-07 Bristol-Myers Squibb Pharma Company Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
WO2015186117A1 (en) 2014-06-06 2015-12-10 Siemens Medical Solutions Usa, Inc. Gamma camera dead time determination in real time using long lived radioisotopes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3048587A (en) * 1960-10-17 1962-08-07 Ortho Pharma Corp 2-alkylamino-4-aminopyrimidine
US3296268A (en) * 1965-10-19 1967-01-03 Searle & Co 3-cyanoethyl-2-oxo-5-phenyl [1, 5-a] pyrimidines

Also Published As

Publication number Publication date
US3920652A (en) 1975-11-18
RO63871A (fr) 1979-01-15
BE786611A (fr) 1973-01-22
IL39988A0 (en) 1972-09-28
SU522800A3 (ru) 1976-07-25
GB1359563A (en) 1974-07-10
ATA677372A (de) 1975-10-15
IE36629L (en) 1973-02-16
NL7211011A (en:Method) 1973-02-20
FR2150771A1 (en:Method) 1973-04-13
BG19806A3 (bg) 1975-10-10
AR193536A1 (es) 1973-04-30
IE36629B1 (en) 1977-01-19
AT330780B (de) 1976-07-26
MC937A1 (fr) 1973-08-10
DE2236987A1 (de) 1973-03-01
DD99581A5 (en:Method) 1973-08-12
HU167466B (en:Method) 1975-10-28
FR2150771B1 (en:Method) 1976-05-21
LU65892A1 (en:Method) 1973-01-15
JPS4834899A (en:Method) 1973-05-22

Similar Documents

Publication Publication Date Title
ES405663A1 (es) Procedimiento para la obtencion de compuestos inhibidores de oxidasa de xantina.
IT1051562B (it) Composizione per substrati per la determinazione quantitativa di enzimi
ES388780A1 (es) Un metodo de preparacion de 1-(bencil sustituido) tetrahi- dro - 2 - (1h) - pirimidona util en la estimulacion del sis-tema nervioso central de animales y seres humanos.
BE789195A (fr) Compositions d'enzymes
ES422001A1 (es) Un procedimiento para la preparacion de nuevas imidazotria-zinas.
CA979833A (en) Enzyme inhibitors of microbial origin
ES423056A1 (es) Procedimiento para la produccion de sulfoxidos.
CA970692A (en) METHODS OF INHIBITING THE ACTIVITY OF TESTOSTERONE 5.alpha.-REDUCTASE
ES389371A1 (es) Procedimiento para la obtencion de derivados de 1-(1,3,4- tiadiazol-2-il)-imidazolidinona-(2).
CA978113A (en) Enzyme stabilization
ES425853A1 (es) Un nuevo procedimiento para la preparacion de compuestos de4,5-dihidrotetrazolo (1,5-a) quinoleina.
CA920524A (en) Method for improving the stability of enzymes
GB1369874A (en) Stabilization of enzyme for lysing cells of dental-caries-inducing micro-organism
ES423716A1 (es) Procedimiento para la obtencion de 1,4-dihidroquinolinas.
IT1016255B (it) Procedimento per l isolamento di 1.5 dinitroantrachinone
IT7924490A0 (it) Procedimento per la produzione di l- -glicerofosfato ossidasi.
CA922321A (en) Enzyme inhibitors
CA946837A (en) Enzyme inhibitor
IT8025518A0 (it) Procedimento per la produzione di acil-coa ossidasi.
AR194605A1 (es) Procedimiento para la preparacion de la enzima fibrinolitica 22.750rp
CA1266268C (en) CARDIOTONIC AROYLTHIAZOLONES
GB1353080A (en) Cartons
CA839235A (en) Purification of enzyme inhibitors
AU260293B2 (en) Process forthe manufacture of sulfonamides. ofthe pyrimidine group
AU242563B2 (en) Process forthe stabilization of surface soil